Anne Schuchat | |
---|---|
Principal Deputy Director of the Centers for Disease Control and Prevention | |
In office September 2015 –May 2021 | |
President | Barack Obama Donald Trump Joe Biden |
Preceded by | Ileana Arias |
Succeeded by | Debra Houry (acting) |
Acting Director of the Centers for Disease Control and Prevention | |
In office January 31,2018 –March 26,2018 | |
President | Donald Trump |
Preceded by | Brenda Fitzgerald |
Succeeded by | Robert R. Redfield |
In office January 20,2017 –July 7,2017 | |
President | Donald Trump |
Preceded by | Tom Frieden |
Succeeded by | Brenda Fitzgerald |
Personal details | |
Born | 1960 (age 63–64) |
Education | Swarthmore College (BS) Dartmouth College (MD) |
Website | Government website |
Military service | |
Allegiance | United States |
Branch/service | U.S. Public Health Service |
Years of service | 1999–2018 |
Rank | Rear admiral |
Unit | PHS Commissioned Corps |
Commands | Anthrax Emergency Response Team [1] National Center for Immunization and Respiratory Diseases Interim Deputy Director for Science and Public Health |
Battles/wars | 2001 anthrax attacks SARS outbreak 2009 flu pandemic [2] |
Anne Schuchat (born 1960) is an American medical doctor. She is a former rear admiral and assistant surgeon general in the United States Public Health Service Commissioned Corps. She also served as the principal deputy director of the Centers for Disease Control and Prevention (CDC). [3] [4] In May 2021,Schuchat stepped down from her post. [5]
Schuchat grew up in a Jewish family in Washington,D.C.,the fourth of five children. [6] [7] Her grandfather was a kosher butcher from West Virginia. [7] Schuchat graduated with highest honors from Swarthmore College in 1980 and graduated with honors from Dartmouth Medical School in 1984. [1] [2] [8]
Schuchat served as resident and chief resident in internal medicine at New York University's Manhattan V.A. Hospital before beginning her public health career at CDC as an Epidemic Intelligence Service (EIS) officer in NCID.[ clarification needed ] [9]
Having worked with the CDC on immunization,respiratory,and other infectious diseases since 1988,she served as the Interim Deputy Director for Science and Public Health at the CDC from February 2009 to June 2009. She has also held other posts in the CDC. [9]
During the 2001 anthrax attacks,Schuchat served on CDC's Anthrax Emergency Response Team,which was tasked with investigating the attacks. [1]
From February 2009 to June 2009,Schuchat was the Interim Deputy Director for Science and Public Health Program at the CDC,where she focused on ensuring strong science and programmatic approaches were effectively integrated into planning across the agency. She has emphasized prevention of infectious diseases in children. Her emphasis on perinatal group B streptococcal disease prevention has led to an 80 percent reduction in newborn infections and a 75 percent narrowing of racial disparities among sufferers of this infectious disease. She has been instrumental in pre- and post-licensure evaluations of conjugate vaccines for bacterial meningitis and pneumonia and in accelerating availability of these new vaccines in resource-poor countries through WHO and the Global Alliance for Vaccines and Immunization. [9]
From January 20,2017 through July 7,2017,Schuchat served as Acting Director of the CDC (and as acting Administrator for the Agency for Toxic Substances and Disease Registry) and again from January 31,2018 through March 26,2018,when she was succeeded by Robert R. Redfield as Director. [10] [11] [12]
Schuchat has been active in the CDC's efforts to combat the 2020 Coronavirus outbreak in the United States. In a February 25,2020 HHS briefing on the "China coronavirus" she famously stated "It’s very important to say that our efforts at containment so far have worked,and the virus is actually contained here in the United States." [13] A May 1,2020 CDC report authored by Schuchat noted that based on this containment belief federal and local jurisdictions did not recommend restrictions on gatherings,and that several large events consequently held at the end of February played a notable role in the spread of COVID-19 in the United States. [14]
In a valedictory retirement message,Schuchat wrote that “public health successes usually take place out of the spotlight and under the radar,which for most of us in this field is just fine;victory often means preventing something bad from happening”and,acknowledging that “the Covid-19 pandemic [was] as large a disrupter as a world war,”expressed "hope this is also a moment when a new generation is called to action,to experience the difficulty and meaning and joy of public service. Our world needs you." [15]
Schuchat is married and has no children;she has three brothers and one sister. [6] [7] In May 2005,Schuchat received an honorary doctorate in science from Swarthmore College,from which she graduated in 1980. [1] [8] [9]
The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.
The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.
Immunization, or immunisation, is the process by which an individual's immune system becomes fortified against an infectious agent. When this system is exposed to molecules that are foreign to the body, called non-self, it will orchestrate an immune response, and it will also develop the ability to quickly respond to a subsequent encounter because of immunological memory. This is a function of the adaptive immune system. Therefore, by exposing a human, or an animal, to an immunogen in a controlled way, its body can learn to protect itself: this is called active immunization. The most important elements of the immune system that are improved by immunization are the T cells, B cells, and the antibodies B cells produce. Memory B cells and memory T cells are responsible for a swift response to a second encounter with a foreign molecule. Passive immunization is direct introduction of these elements into the body, instead of production of these elements by the body itself.
The DPT vaccine or DTP vaccine is a class of combination vaccines to protect against three infectious diseases in humans: diphtheria, pertussis, and tetanus (lockjaw). The vaccine components include diphtheria and tetanus toxoids, and either killed whole cells of the bacterium that causes pertussis or pertussis antigens. The term toxoid refers to vaccines which use an inactivated toxin produced by the pathogen which they are targeted against to generate an immune response. In this way, the toxoid vaccine generates an immune response which is targeted against the toxin which is produced by the pathogen and causes disease, rather than a vaccine which is targeted against the pathogen itself. The whole cells or antigens will be depicted as either "DTwP" or "DTaP", where the lower-case "w" indicates whole-cell inactivated pertussis and the lower-case "a" stands for "acellular". In comparison to alternative vaccine types, such as live attenuated vaccines, the DTP vaccine does not contain any live pathogen, but rather uses inactivated toxoid to generate an immune response; therefore, there is not a risk of use in populations that are immune compromised since there is not any known risk of causing the disease itself. As a result, the DTP vaccine is considered a safe vaccine to use in anyone and it generates a much more targeted immune response specific for the pathogen of interest.
Julie Louise Gerberding is an American infectious disease expert who was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). As of May 2022, she is the CEO of the Foundation for the National Institutes of Health (FNIH). Gerberding grew up in Estelline, South Dakota, attended Brookings High School, and earned undergraduate and graduate degrees from Case Western Reserve University. She was the chief medical resident at the University of California, San Francisco where she treated hospitalized AIDS patients in the first years of the epidemic. Gerberding became a nationally-recognized figure during the 2001 anthrax attacks in the United States during her tenure as the acting deputy director of the National Center for Infectious Diseases, where she was a prominent spokeswoman for the CDC during daily briefings regarding the attacks and aftermath. Gerberding then served as CDC director from 2002-2009, and was then hired as an administrator at Merck.
A vaccination schedule is a series of vaccinations, including the timing of all doses, which may be either recommended or compulsory, depending on the country of residence. A vaccine is an antigenic preparation used to produce active immunity to a disease, in order to prevent or reduce the effects of infection by any natural or "wild" pathogen. Vaccines go through multiple phases of trials to ensure safety and effectiveness.
Anthrax vaccines are vaccines to prevent the livestock and human disease anthrax, caused by the bacterium Bacillus anthracis.
The MMRV vaccine is a combination vaccine which combines the attenuated virus measles, mumps, rubella, and varicella (chickenpox). The MMRV vaccine has similar immunogenicity and overall safety profiles to the MMR vaccine administered with or without the varicella vaccine. The MMRV vaccine is typically given to children between one and two years of age.
The National Center for Immunization and Respiratory Diseases (NCIRD), formerly known as the National Immunization Program until April 2006, is charged with responsibility for the planning, coordination, and conduct of immunization activities in the United States. NCIRD is a part of the Centers for Disease Control and Prevention, located in Atlanta, Georgia, and housed in the CDC's Coordinating Center for Infectious Diseases (CCID). The National Center for Immunization provides consultation, training, statistical, promotional, educational, epidemiological, and technical services to assist state and local health departments across the US in planning, developing, contracting and implementing immunization programs.
Pneumococcal conjugate vaccine is a pneumococcal vaccine made with the conjugate vaccine method and used to protect infants, young children, and adults against disease caused by the bacterium Streptococcus pneumoniae (pneumococcus). It contains purified capsular polysaccharide of pneumococcal serotypes conjugated to a carrier protein to improve antibody response compared to the pneumococcal polysaccharide vaccine. The World Health Organization (WHO) recommends the use of the conjugate vaccine in routine immunizations given to children.
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine are more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin. Another vaccine, known as zoster vaccine, is used to prevent diseases caused by the same virus – the varicella zoster virus.
Measles vaccine protects against becoming infected with measles. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When the rate of vaccination within a population is greater than 92%, outbreaks of measles typically no longer occur; however, they may occur again if the rate of vaccination decreases. The vaccine's effectiveness lasts many years. It is unclear if it becomes less effective over time. The vaccine may also protect against measles if given within a couple of days after exposure to measles.
Katherine "Kate" L. O'Brien is a Canadian American pediatric infectious disease physician, epidemiologist, and vaccinologist who specializes in the areas of pneumococcal epidemiology, pneumococcal vaccine trials and impact studies, and surveillance for pneumococcal disease. She is also known as an expert in infectious diseases in American Indian populations. O’Brien is currently the Director of the World Health Organization's Department of Immunization, Vaccines and Biologicals.
In 1976, an outbreak of the swine flu, influenza A virus subtype H1N1 at Fort Dix, New Jersey caused one death, hospitalized 13, and led to a mass immunization program. After the program began, the vaccine was associated with an increase in reports of Guillain–Barré syndrome (GBS), which can cause paralysis, respiratory arrest, and death. The immunization program was ended after approximately 43 million United States citizens had been administered the vaccine.
The Vaccines for Children Program (VFC) is a federally funded program in the United States providing no-cost vaccines to children who lack health insurance or who otherwise cannot afford the cost of the vaccination. The VFC program was created by the Omnibus Budget Reconciliation Act of 1993 and is required to be a new entitlement of each state's Medicaid plan under section 1928 of the Social Security Act. The program was officially implemented in October 1994 and serves eligible children in all U.S. states, as well as the Commonwealth of Puerto Rico, the U.S. Virgin Islands, American Samoa, Guam, and the Commonwealth of the Northern Mariana Islands.
Tetanus vaccine, also known as tetanus toxoid (TT), is a toxoid vaccine used to prevent tetanus. During childhood, five doses are recommended, with a sixth given during adolescence.
Walter A. Orenstein served as the director of the United States' National Immunization Program, from May 1993 to January 2004.
Stephen C. Redd is a U.S. physician and rear admiral with the U.S. Public Health Service and an Assistant Surgeon General. With over 30 years of public health and executive leadership experience, Redd served as the Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention. Previously, he was the Director of the CDC's Influenza Coordination Unit, where he served as the incident commander for the 2009-2010 H1N1 pandemic influenza response.
Nancy Messonnier is an American physician who served as the director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention from 2016 to 2021. She worked on the CDC's response to the COVID-19 pandemic in the United States.
Since 1980, the U.S. Centers for Disease Control and Prevention has been organized around constituent centers, institutes, and offices (CIOs). Five centers were created in 1980, which was reflected in CDC's contemporaneous name change from the singular "Center" to plural "Centers". The current centers are descended from these five, with the exception of the National Institute for Occupational Safety and Health and National Center for Health Statistics, which were absorbed from outside CDC and have much longer histories.
{{cite journal}}
: CS1 maint: numeric names: authors list (link){{cite news}}
: CS1 maint: url-status (link)The 54th Annual CDC & ATSDR Honor Awards Ceremony was held July 13, 2006, in the Tom Harkin Global Communications Center on the Roybal Campus. To report the awards won by CCID employees, in this summary we are using the then existing, not the proposed, names of the CCID national centers: National Center for Infectious Diseases (NCID), National Immunization Program (NIP), and National Center for HIV, STD, and TB Prevention (NCHSTP).
Media related to Anne Schuchat at Wikimedia Commons